Epigenome-wide association study in a large admixture cohort reveals immune and stress response epigenetic alterations in cocaine use disorder
This epigenome-wide association study of 1,250 Brazilian adults identifies a predominantly hypomethylated peripheral immune-stress profile in cocaine use disorder that is distinct from, yet partially influenced by, concurrent tobacco use, trauma, and polysubstance exposure.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Addiction is often understood as a battle fought within the mind, a struggle of will against a powerful chemical pull. Yet, the effects of substance use disorders extend far beyond the brain, leaving a measurable mark on the body's most fundamental biological instructions. Inside nearly every cell, DNA acts as a master blueprint, but it is not the only layer of control. Wrapped around this blueprint is a chemical coating called the epigenome, which functions like a set of dimmer switches. These switches do not change the text of the blueprint itself; instead, they determine which genes are turned on, how loudly they sing, and which ones are silenced. This system allows the body to adapt to its environment, but when the environment is filled with chronic stress or repeated exposure to drugs, these switches can get stuck in the wrong position, altering how the body functions and responds to the world.
Scientists have long suspected that the compulsive use of cocaine leaves a specific signature on these epigenetic switches, but proving this has been difficult. The challenge lies in the messy reality of human lives: people who struggle with cocaine use often face other hardships, such as trauma, poverty, and the use of other substances like tobacco. Untangling the specific biological effects of cocaine from the effects of these other factors requires a massive amount of data and a very careful approach. A new study has taken on this challenge, looking at the blood of over a thousand people to find out exactly what changes occur in their genetic instructions when they are caught in the grip of cocaine use disorder.
The researchers gathered a large group of adults from Brazil, including 563 individuals diagnosed with cocaine use disorder and 687 people who did not use the drug. They collected blood samples from everyone and mapped the chemical switches across the entire genome, looking for patterns that differed between the two groups. To ensure they were seeing the true effects of cocaine and not just the side effects of other factors, they carefully adjusted their analysis to account for age, sex, ancestry, and the specific types of cells in the blood. They also paid close attention to the heavy overlap of tobacco use and past traumatic events, which are common in this population.
The study revealed a clear and widespread pattern of change. The researchers found dozens of specific spots on the genetic blueprint where the chemical switches were significantly different in people with cocaine use disorder. Most of these changes involved the switches being turned down, a state known as hypomethylation, which often leads to genes being more active than usual. These changes were not random; they clustered around genes that control the body's immune system and its response to stress. Specifically, the altered genes were involved in how the body fights infection, how it signals between cells to coordinate a defense, and how it manages the stress response. This suggests that the body of someone with cocaine use disorder is in a constant state of heightened alert, as if it were preparing to fight an infection or recover from an injury, even when no immediate threat is present.
One of the most significant findings was how much of this biological picture was shaped by factors other than cocaine itself. The researchers discovered that while the overall pattern was linked to the disorder, specific parts of it were driven by different life experiences. For instance, the use of tobacco explained a small but expected portion of the changes, particularly in genes known to react to smoking. However, the study showed that tobacco use alone could not explain the majority of the findings. Instead, the history of using multiple substances, such as alcohol and cannabis, and the burden of past traumatic events each left their own distinct fingerprints on the genetic switches. One gene, known for its role in how the body handles stress, was particularly sensitive to the number of traumatic events a person had experienced. This indicates that the biological impact of cocaine use is not a single, simple signal, but a complex layering of effects from drugs, trauma, and other substances.
To understand if these changes in the blood reflected what was happening in the brain, the researchers compared their blood findings with data from brain tissue samples taken after death. They found that while the blood and brain did not show the exact same changes everywhere, there was a meaningful overlap in specific areas. Certain genes related to cell movement and immune signaling showed similar patterns of change in both the blood and the brain. This suggests that the immune and stress-related alterations seen in the blood are likely connected to the biological changes occurring in the brain, offering a way to study the disease through a simple blood test. However, the study also confirmed that the brain and blood are not identical; some changes were unique to the brain, highlighting that the body's response to addiction is complex and varies by tissue.
The study concludes that cocaine use disorder is a systemic condition that reshapes the body's biological instructions, creating a profile of immune activation and stress regulation that is distinct from the effects of smoking or other drugs alone. By separating the signal of cocaine from the noise of other life experiences, the researchers have identified a set of genetic markers that point toward a body in a state of chronic, low-level alarm. These findings do not offer a cure, but they provide a clearer map of the biological terrain, showing that the damage of addiction is written into the very instructions that tell our cells how to behave. This deeper understanding of how trauma, stress, and drugs combine to alter our biology may one day help doctors develop better ways to treat the disorder, moving beyond the symptoms to address the underlying biological shifts that keep the cycle of addiction going.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.